South Korean artificial intelligence (AI) developer Vuno has gone public after the Korean stock market approved the company's listing.
The Korea Exchange approved Vuno's inclusion in the secondary bourse, KOSDAQ, for an initial public offering (IPO) of 37.8 billion South Korean Won ($33.5 million U.S.) through the issuance of 1.8 million shares.
The IPO was priced at 21,000 South Korean Won ($18.64) per share, which was above Vuno's desired range of 15,000-19,500 South Korean Won ($13.31-$17.31).
Vuno plans to use the funds to invest in research and development as well as hire scientists in the fields of medicine, AI, and technology. The firm also plans to build partnerships with major players in the healthcare space, Vuno said.
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
